FASN, fatty acid synthase, 2194

N. diseases: 215; N. variants: 6
Source: BEFREE ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.040 Biomarker disease BEFREE Furthermore, either PKM2 inhibitor-Shikonin or FASN inhibitor-TVB-3166 alone induced a strong antiproliferative and anticolony forming effect in bladder cancer cell line. 30221356 2019
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.040 AlteredExpression disease BEFREE The results showed that GA inhibited fatty acid synthase (FAS) activity and increased ER alpha level of TSGH-8301 bladder cancer cell. 29567231 2018
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.040 GeneticVariation disease BEFREE Our study provides new evidence that FAS-1377 G and FASL-844 T alleles may be used as low-penetrant risk factors for bladder cancer development in a Turkish population. 24815844 2015
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.040 Biomarker disease BEFREE To investigate the status of fatty acid synthase (FAS) in bladder tumors and evaluate its prognostic significance, we immunohistochemically examined the expression of FAS in normal urothelium, carcinoma in situ (CIS), and urothelial carcinoma (UC) in cystectomized bladder. 21922386 2011